Key Takeaways Iopofosine-131 has been granted breakthrough therapy designation by the FDA for relapsed or refractory Waldenstrom macroglobulinemia, indicating its potential to improve treatment ...

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Pavel and others Annals of Oncology, 2020. Volume 31, Issue 5 Current ...

PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop) to ...

Iodine i 131 apamistamab is under clinical development by Actinium Pharmaceuticals and currently in Phase I for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). According to GlobalData, ...

Iopofosine I 131 works by delivering iodine-131 (a cancer-killing radiopharmaceutical used to treat thyroid cancer) directly to cancer cells. Waldenstrom's macroglobulinemia is typically treated with ...

New beta-decay measurements in mirror nuclei pin down the weak nuclear force Scientists develop a new method to characterize the properties of one of the four fundamental forces of nature Date ...

Scientists have gained insights into the weak nuclear force from new, more sensitive studies of the beta decays of the “mirror” nuclei lithium-8 and boron-8. The weak nuclear force ...

Scintillation Spectrometer Studies on the Decay Schemes of Silver-110, Antimony-124 and Iodine-131 S. ALMQVIST & SVEN A. E. JOHANSSON Nature 170, 583–584 (1952) Cite this article ...